 |
PDBsum entry 6haw
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Electron transport
|
PDB id
|
|
|
|
6haw
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
438 a.a.
|
 |
|
|
|
|
|
|
|
413 a.a.
|
 |
|
|
|
|
|
|
|
378 a.a.
|
 |
|
|
|
|
|
|
|
239 a.a.
|
 |
|
|
|
|
|
|
|
196 a.a.
|
 |
|
|
|
|
|
|
|
99 a.a.
|
 |
|
|
|
|
|
|
|
74 a.a.
|
 |
|
|
|
|
|
|
|
64 a.a.
|
 |
|
|
|
|
|
|
|
46 a.a.
|
 |
|
|
|
|
|
|
|
59 a.a.
|
 |
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Electron transport
|
 |
|
Title:
|
 |
Crystal structure of bovine cytochrome bc1 in complex with 2-pyrazolyl quinolone inhibitor wdh2g7
|
|
Structure:
|
 |
Cytochrome b-c1 complex subunit 1, mitochondrial. Chain: a. Synonym: complex iii subunit 1,core protein i,ubiquinol-cytochromE-C reductase complex core protein 1. Cytochrome b-c1 complex subunit 2, mitochondrial. Chain: b. Cytochrome b. Chain: c. Synonym: complex iii subunit 3,complex iii subunit iii,cytochrome b-
|
|
Source:
|
 |
Bos taurus. Cattle. Organism_taxid: 9913. Organism_taxid: 9913
|
|
Resolution:
|
 |
|
3.45Å
|
R-factor:
|
0.212
|
R-free:
|
0.242
|
|
|
Authors:
|
 |
K.Amporndanai,W.D.Hong,P.M.O'Neill,S.S.Hasnain,S.V.Antonyuk
|
|
Key ref:
|
 |
W.David Hong
et al.
(2018).
Potent Antimalarial 2-Pyrazolyl Quinolone bc1 (Qi) Inhibitors with Improved Drug-like Properties.
ACS Med Chem Lett,
9,
1205-1210.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
08-Aug-18
|
Release date:
|
16-Jan-19
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P31800
(QCR1_BOVIN) -
Cytochrome b-c1 complex subunit 1, mitochondrial from Bos taurus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
480 a.a.
438 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P23004
(QCR2_BOVIN) -
Cytochrome b-c1 complex subunit 2, mitochondrial from Bos taurus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
453 a.a.
413 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P00157
(CYB_BOVIN) -
Cytochrome b from Bos taurus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
379 a.a.
378 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P00125
(CY1_BOVIN) -
Cytochrome c1, heme protein, mitochondrial from Bos taurus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
325 a.a.
239 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P13272
(UCRI_BOVIN) -
Cytochrome b-c1 complex subunit Rieske, mitochondrial from Bos taurus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
274 a.a.
196 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P00129
(QCR7_BOVIN) -
Cytochrome b-c1 complex subunit 7 from Bos taurus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
111 a.a.
99 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P13271
(QCR8_BOVIN) -
Cytochrome b-c1 complex subunit 8 from Bos taurus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
82 a.a.
74 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P00126
(QCR6_BOVIN) -
Cytochrome b-c1 complex subunit 6, mitochondrial from Bos taurus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
91 a.a.
64 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class 2:
|
 |
Chains A, B, C, F, G, H, J:
E.C.?
|
|
 |
 |
 |
 |
 |
Enzyme class 3:
|
 |
Chains D, E, I:
E.C.7.1.1.8
- quinol--cytochrome-c reductase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
a quinol + 2 Fe(III)-[cytochrome c](out) = a quinone + 2 Fe(II)- [cytochrome c](out) + 2 H(+)(out)
|
 |
 |
 |
 |
 |
quinol
|
+
|
2
×
Fe(III)-[cytochrome c](out)
|
=
|
quinone
|
+
|
2
×
Fe(II)- [cytochrome c](out)
|
+
|
2
×
H(+)(out)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
ACS Med Chem Lett
9:1205-1210
(2018)
|
|
PubMed id:
|
|
|
|
|
| |
|
Potent Antimalarial 2-Pyrazolyl Quinolone bc1 (Qi) Inhibitors with Improved Drug-like Properties.
|
|
W.David Hong,
S.C.Leung,
K.Amporndanai,
J.Davies,
R.S.Priestley,
G.L.Nixon,
N.G.Berry,
S.Samar Hasnain,
S.Antonyuk,
S.A.Ward,
G.A.Biagini,
P.M.O'Neill.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
A series of 2-pyrazolyl quinolones has been designed and synthesized in 5-7
steps to optimize for both in vitro antimalarial potency and various
in vitro drug metabolism and pharmacokinetics (DMPK) features. The most
potent compounds display no cross-resistance with multidrug resistant parasite
strains (W2) compared to drug sensitive strains (3D7), with IC50
(concentration of drug required to achieve half maximal growth suppression)
values in the range of 15-33 nM. Furthermore, members of the series retain
moderate activity against the atovaquone-resistant parasite isolate (TM90C2B).
The described 2-pyrazoyl series displays improved DMPK properties, including
improved aqueous solubility compared to previously reported quinolone series and
acceptable safety margin through in vitro cytotoxicity assessment. The
2-pyrazolyl quinolones are believed to bind to the ubiquinone-reducing
Qi site of the parasite bc1 complex, which is
supported by crystallographic studies of bovine cytochrome bc1
complex.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
| | |